通过代谢功能障碍相关的脂肪性肝病活检中的肝纤维化模式来预测肝癌发生
Asami Beppu1, Hisamitsu Miyaaki2, Satoshi Miuma1
1Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
Medical molecular morphology
|June 5, 2025
概括
人工智能在与代谢功能障碍相关的脂肪性肝病 (MASLD) 中确定了特定的纤维化模式,预测肝细胞癌 (HCC) 的发展. 这些人工智能驱动的纤维化特征可以帮助对患有MASLD的患者进行分层,以确定致癌风险.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 人工智能在医学中的应用
- 在瘤学瘤学.
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是慢性肝病和肝细胞癌 (HCC) 的日益严重的原因.
- 在MASLD中纤维化模式是复杂的,它们与致癌的关联需要进一步调查.
- 在MASLD患者中,对HCC的准确风险分层对于及时干预至关重要.
研究的目的:
- 用人工智能研究MASLD肝活检组织中与癌症发生相关的纤维化模式.
- 量化和评估各种纤维化模式及其与HCC发展的相关性.
- 评估人工智能驱动的纤维化分析对预测MASLD中HCC风险的潜力.
主要方法:
- 使用FibroNest AI对13名晚期纤维化MASLD患者的肝脏活检组织进行分析.
- 使用七个定量纤维化参数 (qFPs) 来量化原蛋白和评估形态/结构纤维特征.
- 在HCC和非HCC组之间比较纤维化得分 (FCS,形态-FCS,架构-FCS,表型-FCS [Ph-FCS]).
主要成果:
- 仅仅通过对原蛋白的量化,就无法区分HCC和非HCC病例.
- 特定的定量纤维化参数 (纤维扭曲曲率/度,纤维宽度/密度曲率,纤维长度曲率) 在HCC和非HCC组之间显示出显著的差异.
- 现型FCS在区分HCC与非HCC方面表现出高精度 (85%的灵敏度,100%的特异性).
结论:
- 基于AI的纤维化形态和结构分析可以准确地预测MASLD患者的HCC发展.
- 具体的定量纤维化参数为MASLD的致癌机制提供了洞察力.
- 这种AI方法可能有助于在MASLD人群中定义致癌风险组.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
245
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
245
Ultrasound II: Endoscopic Ultrasound and FibroScan
935
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
935
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
304
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
304
Liver Regeneration
4.6K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.6K


